Skip to Main Content Skip to Site Map Skip to Accessibility Statement

Head & Neck Cancer

Trial The Adept DDR Trial
Cancer Type Head & Neck Cancer
Hospital(s) Belfast City Hospital
Information

Accelerating the Development and implementation of Personalised Treatments of DNA Damage Response agents and radiotherapy +/- immunotherapy for head and neck squamous cell cancer

Click Here to view Cancer Research UK trial summary
Trial NG11-2-P1b
Cancer Type Head & Neck Cancer
Hospital(s) Belfast City Hospital
Information

A Phase-1b Dose Escalation Study to Assess the Effect of NG11-2 on Radiation Induced Oral Mucositis in Patients with Head & Neck Cancer